Gastrointestinal Cancer News

Patients with pancreatic cancer who received neoadjuvant therapy before pancreatoduodenectomy exhibited biliary microbiome alterations, according to study results.

Cologuard, a non-invasive colorectal cancer screening test, has been approved for use in at-risk patients aged 45 and older.

The Seattle Cancer Care Alliance, the clinical care partner of the Fred Hutchinson Cancer Research Center, has been at the forefront of cellular therapies for cancer treatment since the field emerged. It was there where E. Donnall Thomas, MD, and his team pioneered the use of bone marrow transplant during the 1970s and SCCA’s position remains unchanged in the field of cellular therapies as its research and clinical staff have administered more CAR T-cell therapies to patients than any other facility in the world.

The American Association for Cancer Research today released its annual Cancer Progress Report, which reflects how prior investment in the NIH is paying dividends in terms of advances across the spectrum of cancer care.

BARCELONA — The International Association for the Study of Lung Cancer, or IASLC, today issued a declaration at its World Conference on Lung Cancer advising all physicians to screen their patients with cancer for tobacco use and recommend tobacco cessation.

The Laboratory for Advanced Medicine announced via a press release that the FDA granted breakthrough device designation to its liquid biopsy liver cancer detection test.

The Association of Community Cancer Centers will present awards to three oncology professionals at its 36th National Oncology Conference, which will be held Oct. 30 to Nov. 1 in Orlando.

Adults with type 2 diabetes who are treated with DPP-IV inhibitors are more likely to develop pancreatitis and pancreatic cancer compared with those treated with other medications, according to findings published in Diabetes Care.

Oncologic randomized clinical trials published between 2003 and 2018 exhibited a low rate of female corresponding authorship in relation to the overall percentage of female academic oncologists during the period, according to a research letter published in JAMA Oncology.

High-value care appeared associated with important patient, tumor and treatment characteristics among patients with early-stage pancreatic cancer who underwent curative resection, according to results of a retrospective study published in JAMA Surgery.